Evidence map›Paper›PMID 40140867›Full record

ArticleMalaria journal2025

Prevalence of subpatent Plasmodium falciparum infections in regions with varying transmission intensities and implications for malaria elimination in Mainland Tanzania.

Misago D Seth, Zachary R Popkin-Hall, Rashid A Madebe, Rule Budodo, Catherine Bakari, Beatus M Lyimo, David Giesbrecht, Ramadhani Moshi, Ruth B Mbwambo, Filbert Francis and 15 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Genetic metrics decodeFrontiers in genetics · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Misago D SethNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania. sethmdj@gmail.com.
Zachary R Popkin-HallUniversity of North Carolina, Chapel Hill, NC, USA.
Rashid A MadebeNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Rule BudodoNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Catherine BakariNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Beatus M LyimoNelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
David GiesbrechtThe Connecticut Agricultural Experiment Station, New Haven, CT, USA.
Ramadhani MoshiNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Ruth B MbwamboNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Filbert FrancisNational Institute for Medical Research, Tanga, Tanzania.
Dativa PereusNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Doris MbataNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Daniel P ChalleNational Institute for Medical Research, Tanga, Tanzania.
Salehe S MandaiNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Gervas A ChachaNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Angelina J KisambaleNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Daniel MbwamboNational Malaria Control Programme, Dodoma, Tanzania.
Sijenunu AaronNational Malaria Control Programme, Dodoma, Tanzania.
Abdallah LusasiNational Malaria Control Programme, Dodoma, Tanzania.
Samwel LazaroNational Malaria Control Programme, Dodoma, Tanzania.
Celine I MandaraNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Jeffrey A BaileyBrown University, Providence, RI, USA.
Jonathan J JulianoUniversity of North Carolina, Chapel Hill, NC, USA.
Julie R GutmanCenters for Disease Control and Prevention, Atlanta, GA, USA.
Deus S IshengomaNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.

Funding

Bill and Melinda Gates Foundation INV 002202Gates Foundation INV-002202
6 · The paper itself

Abstract

backgroundSubpatent Plasmodium falciparum infections, defined as infections with parasite density below the detection limit of routine malaria diagnostic tests, contribute to infectious reservoirs, sustain transmission, and cause the failure of elimination strategies in target areas. This study assessed the prevalence of subpatent P. falciparum infections and associated risk factors in 14 regions of Mainland Tanzania.

methodsThe study used samples randomly selected from RDT-negative dried blood spots (DBS) (n = 2685/10,101) collected in 2021 at 100 health facilities across 10 regions of Mainland Tanzania, and four communities in four additional regions. The regions were selected from four transmission strata; high (five regions), moderate (three regions), low (three regions), and very low (three regions). DNA was extracted by Tween-Chelex method, and the Pf18S rRNA gene was amplified by quantitative polymerase chain reaction (qPCR). Logistic regression analysis was used to assess the associations between age groups, sex, fever status, and transmission strata with subpatent infection status, while linear regression analysis was used to assess the association between these factors and subpatent parasite density.

resultsOf the selected samples, 525/2685 (19.6%) were positive by qPCR for P. falciparum, and the positivity rates varied across different regions. Under-fives (aOR: 1.4, 95% CI 1.04-1.88; p < 0.05) from health facilities had higher odds of subpatent infections compared to other groups, while those from community surveys (aOR: 0.33, 95% CI 0.15-0.72; p = 0.005) had lower odds. Participants from very low transmission stratum had significantly lower odds of subpatent infection compared to those from high transmission stratum (aOR = 0.53, 95% CI = 0.37-0.78; p < 0.01). The log-transformed median parasite density (interquartile range) was 6.9 (5.8-8.5) parasites/µL, with significantly higher parasitaemia in the low transmission stratum compared to a very low one (11.4 vs 7.0 parasites/µL, p < 0.001).

conclusionEven in very low transmission settings, the prevalence of subpatent infections was 13%, and in low transmission settings it was even higher at 29.4%, suggesting a substantial reservoir that is likely to perpetuate transmission but can be missed by routine malaria case management strategies. Thus, control and elimination programmes may benefit from adoption of more sensitive detection methods to ensure that a higher proportion of subpatent infections are detected.

Indexed as

Disease EradicationMalaria, FalciparumPlasmodium falciparumAdolescentAdultAgedAsymptomatic InfectionsChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedPrevalenceMalariaPlasmodium falciparumqPCRRapid diagnostic testsSubpatent infectionsTanzania

Identifiers

PMID40140867
PMCPMC11948789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.